![](/img/cover-not-exists.png)
PCV72 COST-EFFECTIVENESS OF ROSUVASTATIN FOR THE PRIMARY PREVENTION OF VASCULAR EVENTS ACCORDING TO FRAMINGHAM RISK SCORE IN PATIENTS WITH AN ELEVATED C-REACTIVE PROTEIN
GP MacDonaldVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72791-1
File:
PDF, 68 KB
english, 2010